Progression-Free Survival

Progression-Free Survival (PFS) is the time from randomization to disease progression or death. According to international standards like FDA 21 CFR Part 314.104 and EMA guidelines, PFS is a critical endpoint for evaluating drug efficacy. In enterprise risk management, PFS data--representing product stability and efficacy—must be rigorously tracked to ensure regulatory compliance and to mitigate risks related to drug approval and market-entry. This requires robust data--gathering, storage, and analysis systems that meet both clinical and information security standards, such as ISO 27701, to prevent data--related regulatory actions.

Enterprise risk management（ERM）utilizes PFS data through three key steps: First, establishing a data--collection and monitoring mechanism compliant with GCP（Good Clinical Practice）to ensure data integrity. Second, implementing a risk-trigger system where PFS results below pre-defined thresholds initiate a formal risk-assessment process. Third, using PFS outcomes to adjust commercialization strategies, such as adjusting pricing or marketing focus. For instance, a company with a PFS of 6.1 months in a Phase II trial must be closely closely monitoring this metric to manage expectations of regulators and investors, ensuring the company's financial and reputational risk--adjusted planning remains accurate.

Taiwan enterprises typically face three challenges: first, insufficient data-governance capabilities, which can be addressed by adopting ISO 27701 standards for patient data protection; second, the need for cross-departmental collaboration between clinical, regulatory, and commercial teams, which requires a centralized risk-management framework; third, the rapidly evolving regulatory environment in Taiwan, requiring continuous monitoring of TFDA（Taiwan Food and Drug Administration）guidelines. To overcome these, companies should prioritize building a data--centric risk-management culture, invest in digital compliance tools, and ensure staff are trained in both clinical data-handling and risk-assessment methodologies within the first 90 days of implementation.

Winners Consulting Services Co., Ltd. specializes in Progression-Free Survival for Taiwan enterprises, delivering compliant management systems within 90 days. Free consultation: https://winners.com.tw/contact